0001237899-20-000012.txt : 20200225
0001237899-20-000012.hdr.sgml : 20200225
20200225160536
ACCESSION NUMBER: 0001237899-20-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200224
FILED AS OF DATE: 20200225
DATE AS OF CHANGE: 20200225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YANCOPOULOS GEORGE
CENTRAL INDEX KEY: 0001226690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 20650612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-02-24
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001226690
YANCOPOULOS GEORGE
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
President and Chief Scientific
Common Stock
2020-02-24
4
S
0
118123
420.17
D
517799
D
Common Stock
5791
I
By 401(k) Plan
Common Stock
57465
I
by 2018 GRAT
Common Stock
500000
I
by 2019 GRAT
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 118,123 shares of Company stock on February 24, 2020 at prices ranging from $420.00 to $420.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 24, 2020 at each separate price.
/s/**George D. Yancopoulos
2020-02-24